期刊文献+

急性淋巴细胞性白血病跨系表达方式研究 被引量:2

Pattern of Cross-Lineage Expression in Acute Lymphoblastic Leukemia
下载PDF
导出
摘要 目的利用三色流式细胞术对急性淋巴细胞白血病(ALL)免疫表型跨系表达进行研究。方法采用CD45/SSC双参数散点图设门方法对135例ALL(111例B-ALL,24例T-ALL)患者幼稚细胞表面及胞质内分化抗原进行分析。结果在ALL中,髓系抗原(M)表达64%,T和B亚型中髓系抗原表达差异无显著性意义(P>0.05),其中CD13表达最为常见(40%),其次是CD33(37%)、CD11b(20%)和CD15(16%),CD13和CD33在CD34+病例中的表达均高于CD34-病例。B-ALL中,T系抗原CD4、CD2和CD7分别在19例、2例和2例中表达,CD4+和CD7+病例通常共表达CD13和(或)CD33;T-ALL中2例CD19表达者均伴CD13/CD33表达。结论ALL伴髓系表达的频率较高(B+M+,T+M+),偶尔出现B系,T系和髓系共表达的表型(B+T+M+),B系T系共表达但不伴髓系表达的表型(B+T+M-)极少,跨系表达多存在各未成熟的阶段,髓系抗原表达与干细胞表面标志CD34有一定的联系。 Objective To study the cross-lineage expression of acute lymphoblastic leukemia (ALL) with the use of multiparameter flow cytometry in the immunophenotype of ALL. Methods Multiparameter flow cytometry and CD45/SSC gating were used to analyze the surface and cytoplasmic antigen expression in 135 cases of ALL (111 cases of B-ALL and 24 cases of T-ALL). Results In whole ALL, the expression of myeloid antigens occurred in 64 % of the cases, and the expression frequency had no significant tendency in T and B subtypes (P〉0.05). The expression rate of CD13 was highest (40 %), followed by CD33 (37 %), CD11b (20 %) and CD15 (16 %). CD13 and CD33 expression were more frequent in CD34^+ cases than in CD34^- cases. In B-ALL, T-cell antigen CD4, CD2 and CD7 were seen in 19, 2, and 2 cases, respectively, and CD4^+ and CD7^+ cases commonly expressed CD13 and/or CD33 (CD13/CD33). In T-ALL, B-cell antigen CD19 was found in 2 cases with CD13/CD33. Conclusion ALL cells frequently express B^+ M^+ , T^+ M^+ , and occasionally B^+ T^+ M^+ phenotype, but B^+ T^+ M^- phenotype is extremely rare. Cross-lineage expression mostly exists in the immature stages, and myeloid antigens are associated closely with the presence of stem-cell antigen CD34.
出处 《华中科技大学学报(医学版)》 CAS CSCD 北大核心 2006年第3期324-327,共4页 Acta Medicinae Universitatis Scientiae et Technologiae Huazhong
基金 国家"973"科研计划资助项目(No.00CB510103)
关键词 白血病 淋巴细胞性 急性 免疫分型 髓系抗原 跨系表达 leukemia, lymphoblastic, acute immunophenotype myeloid antigen cross-lineage expression
  • 相关文献

参考文献10

  • 1GARCIA VELA J A, MONTESERIN M C, DELGADO I,et al. Aberrant immunophenotypes detected by flow cytometry in acute lymphoblastic leukemia[J]. Leuk Lymphoma,2000,36(3/4):275-284.
  • 2NAKASE K, KITA K, MIWA H, et al. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia[J]. Cancer Detect Prey, 2001, 25(4) :394-405.
  • 3TETTEROO P, GEURTS VAN KESSEL A D. Expression of CD15 (FAL) on myeloid cells and chromosomal localization of the gene[J]. Histochem J, 1992, 24(11):777-782.
  • 4PUTTI M C, RONDELLI R, COCITO M G, et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies[J]. Blood, 1998, 92(3):795-801.
  • 5NAKASE K, KITA K, SHIKU H, et al. Myeloid antigen,CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms[J]. Am J Clin Pathol, 1996, 105(6):761-768.
  • 6HARATA M, SODA Y, TANI K, et al. CD19-targeting liposomes containing imatinib efficiently kill Philadelphia chromosome-positive acute lymphoblastic leukemia cells [J].Blood, 2004, 104(5):1442-1449.
  • 7LOUACHE F, DEBILI N, MARANDIN A, et al. Expression of CD4 by human hematopoietic progenitors[J]. Blood,1994, 84(10):3344-3355.
  • 8UCKUN F M, GAYNON P, SATHER H, et al. Clinical features and treatment outcome of children with biphenotypic CD2^+ CD19^+ acute lymphoblastic leukemia: a children's cancer group study[J]. Blood, 1997, 89(7):2488-2493.
  • 9MIZUTANI M, MIWA H, TAKAHASHI T, et al. Cellular characteristics of acute leukemia cells simultaneously expressing CD13/CD33, CD7 and CD19[J]. Int J Hematol, 1997,66(4):479-491.
  • 10BROWN L C, HUXLEY H M, MACAULAY K,et al. Analysis of the immunophenotypes of de novo acute lymphoblastic leukaemia (ALL) in the Sultanate of Oman[J]. Leuk Res, 2003, 27(7):649-654.

同被引文献9

  • 1龚凡杰,裴敏飞,张广森,肖乐,申建凯,徐运孝.急性淋巴细胞白血病免疫表型与临床特征分析[J].中国医学工程,2004,12(3):37-39. 被引量:2
  • 2王兴兵,姚军霞,郑金娥,刘隽,李小青,贺艳丽,喻竞明,杨晶,魏君,刘仲萍,黄士昂.115例急性髓细胞白血病多参数流式细胞术免疫表型分析[J].中国实验血液学杂志,2005,13(2):250-253. 被引量:20
  • 3Pui CH, Rubnitz JE, Hancock ML, et al. Reappraisal of the clinical and biologic significance of myeloid- associated antigen expression in childhood acute lymphoblastic leukemia. J Clin Oncol, 1998, 16:3768-3773.
  • 4Thomas X, Arehimbaud E, Charrin C, et al. CD34 expression is associated with major adverse prognostie factors in adult acute lymphoblastie leukemia. Leukemia, 1995, 9:249-253.
  • 5Bassan R, Gatta G, Tondini C, et al. Adult acute lymphoblastic leukaemia. Crit Rev Oncol Hematol,2004,50:223-261.
  • 6Bene MC, Castoldi G, Knapp W, et al. Proposals for the immunological classification of acute leukemias. European group for the immunological characterization of leukemias (EGIL). Leukemia, 1995, 9 : 1783-1786.
  • 7Hoelzer D, Gokbuget N. Recent approaches in acute lymphoblastic leukemia in adults. Crit Rev Oncol Hematol, 2000,36:49-58.
  • 8Yanada M, Jinnai I, Takeuchi J, et al. Clinical features and outcome of T-lineage acute lymphoblastic leukemia in adults : a low initial white blood cell count, as well as a high count predict decreased survival rates. Leuk Res, 2007,31: 907-914.
  • 9Putti MC, Cocito MG, Cocito MG, et al. Expression of myeloid markers lacks prognostic impact in children treated for acute lymphoblastic leukemia: Italian experience in AIEOP-ALL 88-91 studies. Blood, 1998,92: 795-801.

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部